Andro-Cyp 200 Drug Interactions
Currently displaying a list of 187 drugs known to interact with Andro-Cyp 200 (testosterone).
- 13 major drug interactions
- 170 moderate drug interactions
- 4 minor drug interactions
Medications known to interact with Andro-Cyp 200
Note: Showing generic names only.
A
- abametapir topical
- acetohexamide
- adagrasib
- amprenavir
- anisindione
- apalutamide
- aprepitant
- armodafinil
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- avacopan
B
- bedaquiline
- belzutifan
- berotralstat
- betamethasone
- binimetinib
- black cohosh
- boceprevir
- bosentan
- brentuximab
- brigatinib
- budesonide
C
- C1 esterase inhibitor (human)
- calaspargase pegol
- calcipotriene topical
- calcitriol topical
- cannabidiol
- carfilzomib
- cenobamate
- chlorpropamide
- clofarabine
- conestat alfa
- conivaptan
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
D
- dabrafenib
- daclizumab
- daridorexant
- darunavir
- dasatinib
- deferasirox
- deflazacort
- dehydroepiandrosterone
- delavirdine
- dexamethasone
- dicumarol
- diltiazem
- dronedarone
- duvelisib
E
F
- fedratinib
- fenfluramine
- fexinidazole
- fidanacogene elaparvovec
- fluconazole
- fludrocortisone
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fostamatinib
G
H
I
- idelalisib
- imatinib
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isavuconazonium
- isoniazid
- itraconazole
K
L
- lapatinib
- larotrectinib
- lefamulin
- leflunomide
- lenacapavir
- letermovir
- levoketoconazole
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lomitapide
- lonapegsomatropin
- lorlatinib
- lusutrombopag
M
- mavacamten
- mavorixafor
- methotrexate
- methylprednisolone
- mibefradil
- mifepristone
- mipomersen
- modafinil
- morphine
N
O
P
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- pirtobrutinib
- pitolisant
- posaconazole
- pralsetinib
- prednisolone
- prednisone
R
- remdesivir
- repaglinide
- repotrectinib
- ribociclib
- rifampin
- rifapentine
- ritlecitinib
- ritonavir
- rucaparib
- rufinamide
S
- saquinavir
- selpercatinib
- sirolimus
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- stiripentol
- suzetrigine
T
- tacrolimus
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- telotristat
- temsirolimus
- teriflunomide
- thioguanine
- thyroid desiccated
- tolazamide
- tolbutamide
- trabectedin
- triamcinolone
- triamcinolone ophthalmic
- trofinetide
- troglitazone
- tucatinib
V
W
Andro-Cyp 200 alcohol/food interactions
There is 1 alcohol/food interaction with Andro-Cyp 200 (testosterone).
Andro-Cyp 200 disease interactions
There are 11 disease interactions with Andro-Cyp 200 (testosterone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- renal/liver disease
- diabetes
- hypercalcemia
- thyroid function tests
Report options
QR code containing a link to this page
More about Andro-Cyp 200 (testosterone)
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.